Supplemental material
Open access
6,552
Views
36
CrossRef citations to date
0
Altmetric
Research Paper
Immunogenicity and safety of an adjuvanted herpes zoster subunit candidate vaccine in adults ≥ 50 years of age with a prior history of herpes zoster: A phase III, non-randomized, open-label clinical trial
Olivier GodeauxGSK Vaccines, Wavre, Belgium
, Martina KovacGSK Vaccines, Wavre, Belgium
, Daniel ShuGain Medical Centre, Coquitlam, BC, Canada
, Katrijn GruppingGSK Vaccines, Wavre, Belgium
, Laura CamporaGSK Vaccines, Wavre, Belgium
, Martine DouhaGSK Vaccines, Wavre, Belgium
, Thomas C. HeinemanGSK Vaccines, King of Prussia, PA, USA
& Himal LalGSK Vaccines, King of Prussia, PA, USACorrespondence[email protected]
show all
Pages 1051-1058
|
Received 08 Sep 2016, Accepted 23 Nov 2016, Published online: 21 Feb 2017
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.